Roivant Sciences Ltd. Common Shares vs SentinelOne Inc. Class A Common Stock — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $24.72B), while SentinelOne Inc. Class A Common Stock trades at $25.65 (market cap $8.84B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 2.8× SentinelOne Inc. Class A Common Stock's market cap, and SentinelOne Inc. Class A Common Stock is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and SentinelOne Inc. Class A Common Stock for 0 Days on average.
| ROIV | S | |
|---|---|---|
Market Cap | $24.72B | $8.84B |
Volume | 6,279,442 | 7,515,091 |
Sector | Health | Technology |
52-Week High | $41.81 | $25.80 |
52-Week Low | $16.04 | $11.94 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $20.99B | $8.23B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →SentinelOne provides an AI-powered cybersecurity platform for organizations. Its Singularity platform helps detect, prevent, and respond to threats across endpoints, cloud workloads, identities, and connected devices.
Read more on S →